Evidence map›Paper›PMID 8842493›Full record

ReviewCancer metastasis reviews1996

The role of angiogenic growth factors in breast cancer progression.

F G Kern, M E Lippman

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Cancer metastasis reviews, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02393833 (Assessment of Vascular Endothelial Growth Factor), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02393833 naterminatednot on this mapstarted 2002, after this paper: background citation

Assessment of Vascular Endothelial Growth Factor (VEGF), Soluble Her2 Protein (NRP, Neu-Related Protein), and Vascular Cellular Adhesion Molecule-1 (VCAM-1) in Serum Samples of Patients Participating in Trial IBCSG 22-00

TypeinterventionalSponsorETOP IBCSG Partners FoundationRan2002 to 2018Enrolled136ConditionsBreast CancerArmsBlood samples collection
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

F G KernLombardi Cancer Center, Department of Biochemistry and Molecular Biology, Georgetown University Medical Center, USA.
M E Lippman
Georgetown University Medical Center · US

Funding

Tissue Culture Shared ResourceP30CA051008 · NCI · GEORGETOWN UNIVERSITY · PI STEPHEN W BYERS · 1990 to 2026
$71.5M
GENETIC MECHANISMS OF BREAST TUMOR PROGRESSIONR01CA050376 · NCI · SOUTHERN RESEARCH INSTITUTE · PI KERN, FRANCIS G. · 1989 to 2004
$2.3M
NCI NIH HHS P30-CA51008NCI NIH HHS P50-CA53185NCI NIH HHS R01-CA50376
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Angiogenesis Inducing AgentsBreast NeoplasmsDisease ProgressionEndothelial Growth FactorsFibroblast Growth FactorsHumansLymphokinesNeovascularization, PathologicVascular Endothelial Growth Factor AVascular Endothelial Growth FactorsAngiogenesis Inducing AgentsEndothelial Growth FactorsFibroblast Growth FactorsLymphokinesVascular Endothelial Growth Factor AVascular Endothelial Growth Factors

Identifiers

PMID8842493
OpenAlexW2079394569

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.